Technical Transfer of a Peptide API from Supplier to Buyer Site

Technical transfer of a peptide API from supplier to buyer site is a structured handover of knowledge, methods, and expectations. It matters when a buyer begins formulation, fills a new market, or brings testing in-house. The transfer should cover the material, the analytical methods, the process history, and the documentation needed for regulatory and quality systems. A weak transfer creates repeated investigations and can delay launch. Procurement and QA teams should treat it as a project with defined deliverables.

Begin with a transfer plan. The plan lists scope, responsibilities, timeline, and acceptance criteria. It should identify what is moving: analytical methods, specifications, reference standards, stability data, and process knowledge. For each item, the plan states the format, the owner, and the evidence of completion. A written plan prevents assumptions and gives both parties a shared view of what success looks like.

Analytical method transfer deserves early attention. The receiving laboratory needs the method, system suitability criteria, sample preparation, and representative chromatograms or spectra. A comparison exercise, sometimes called a co-validation or transfer protocol, shows whether the receiving site can reproduce the supplier's results. Differences in equipment, columns, or software can cause shifts that are not product-related. Documenting these differences helps the receiving site adjust without changing the method's intent.

Reference standards and critical reagents should be part of the package. The buyer needs to know the source, lot, storage conditions, and expiry of any reference material used by the supplier. If the supplier's standard is not available, the transfer plan should describe how an equivalent will be qualified. Without this step, the receiving site may report results that cannot be compared to historical data.

Process knowledge is often the least documented part of a transfer. The supplier may hold information about critical process parameters, purification steps, or handling sensitivities that never appears in a certificate of analysis. A technical transfer meeting or written summary can capture this knowledge. Questions about aggregation, oxidation, or solubility should be answered before the buyer scales or reformulates. This is knowledge transfer, not a claim about clinical performance.

Documentation must align with the buyer's quality system. The receiving site needs specifications, test methods, certificates, and change control records in a format it can file and retrieve. If the supplier uses different terminology or document numbering, the transfer plan should map the differences. QA reviewers check that the buyer can trace each specification back to a source and that no requirement is lost in translation.